NF type1 With Inoperable Plexiform Neurofibromas
1 clinical trials · Condition
◉ Watch NF type1 With Inoperable Plexiform Neurofibromas
| Record | Firm | Date |
|---|---|---|
| An Intermediate Access Protocol for Selumetinib for Treatment of Neurofibromatosis Type 1 (NCT03259633) | AstraZeneca |
Track NF type1 With Inoperable Plexiform Neurofibromas automatically
Every clearance here is in the API, with alerts when new ones post.